13F-HR filed by First Light Asset Management, LLC
First Light Asset Management, LLC filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 52 holding rows worth $364,660,000.
- Accession
- 0001387131-18-000646
- Filer
- CIK 1600004
- Filed
- 2018-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 52 entries on the cover page, a total value of $364,660,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $364,660,000 with VALUE read as thousands by filing date, 13F file number 028-16064. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEOGENOMICS INC | 64049M209 | COM NEW | 3,847,602 | $34,090,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 351,741 | $21,006,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 1,566,804 | $20,055,000 | thousands by filing date | |
| ATRICURE INC | 04963C209 | COM | 1,075,447 | $19,616,000 | thousands by filing date | |
| ENTELLUS MED INC | 29363K105 | COM | 670,904 | $16,363,000 | thousands by filing date | |
| OMNICELL COM COM | 68213N109 | Stock | 317,331 | $15,391,000 | thousands by filing date | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 111,971 | $15,332,000 | thousands by filing date | |
| HARVARD BIOSCIENCE INC | 416906105 | COM | 4,638,651 | $15,308,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 944,404 | $15,262,000 | thousands by filing date | |
| MODEL N INC | 607525102 | COM | 944,125 | $14,870,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 644,764 | $14,133,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 79,607 | $12,349,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 155,904 | $10,764,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 444,004 | $10,518,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 467,646 | $9,475,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 596,778 | $8,337,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 415,573 | $7,771,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 413,721 | $7,488,000 | thousands by filing date | |
| GLOBUS MED INC CL A | 379577208 | Stock | 176,457 | $7,252,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 37,838 | $6,739,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 804,224 | $6,715,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 178,896 | $5,796,000 | thousands by filing date | |
| TELIGENT INC NEW | 87960W104 | COM | 1,503,127 | $5,456,000 | thousands by filing date | |
| QUIDEL CORP | 74838J101 | COM | 119,901 | $5,198,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 791,337 | $5,167,000 | thousands by filing date | |
| BIO-TECHNE CORP | 09073M104 | COM | 38,071 | $4,932,000 | thousands by filing date | |
| K2M GROUP HLDGS INC | 48273J107 | COM | 270,758 | $4,874,000 | thousands by filing date | |
| HEALTHSTREAM INC | 42222N103 | COM | 209,587 | $4,854,000 | thousands by filing date | |
| NXSTAGE MEDICAL INC | 67072V103 | COMMON STOCK | 192,670 | $4,668,000 | thousands by filing date | |
| LHC GROUP | 50187A107 | COM | 68,807 | $4,214,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 23,057 | $3,455,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 31,213 | $2,783,000 | thousands by filing date | |
| IRIDEX CORP | 462684101 | COM | 317,799 | $2,422,000 | thousands by filing date | |
| STREAMLINE HEALTH SOLUTIONS | 86323X106 | COM | 1,375,044 | $2,324,000 | thousands by filing date | |
| ISHARES TR | 464287556 | ISHARES BIOTECH | 21,291 | $2,273,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 41,847 | $2,105,000 | thousands by filing date | |
| Enzo Biochem Inc | 294100102 | Common Stock | 237,054 | $1,932,000 | thousands by filing date | |
| POWERSHARES ETF TR II S&P SMCP | 73937B886 | ETF - EQUITY | 17,285 | $1,703,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 29,533 | $1,616,000 | thousands by filing date | |
| Health Care Select Sector SPDR Fund | 81369Y209 | SHS | 18,241 | $1,508,000 | thousands by filing date | |
| LEMAITRE VASCULAR INC | 525558201 | COM | 46,119 | $1,468,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 13,512 | $1,410,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 73,558 | $1,398,000 | thousands by filing date | |
| iShares U.S. Medical Devices ETF | 464288810 | SHS | 7,580 | $1,315,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 9,499 | $806,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 4,159 | $402,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 8,558 | $310,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 2,183 | $305,000 | thousands by filing date | |
| DYNATRONICS CORP | 268157401 | COM NEW | 104,379 | $301,000 | thousands by filing date | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 3,572 | $300,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 6,720 | $289,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 4,294 | $242,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-18-000646 | this filing | 2018-02-14 | acceptance time not in the bulk data set |